Ever Source Wealth Advisors, LLC Denali Therapeutics Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.25 Billion
- Q1 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 292 shares of DNLI stock, worth $6,348. This represents 0.0% of its overall portfolio holdings.
Number of Shares
292
Previous 258
13.18%
Holding current value
$6,348
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding DNLI
# of Institutions
217Shares Held
115MCall Options Held
142KPut Options Held
90.3K-
Baillie Gifford & CO14MShares$305 Million0.23% of portfolio
-
Black Rock Inc. New York, NY12.2MShares$265 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11MShares$238 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.27MShares$180 Million0.03% of portfolio
-
State Street Corp Boston, MA6.32MShares$137 Million0.01% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.92B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...